OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to agitation in Alzheimer's disease, early detection of PTSD, mental health parity and coordinated care, mental health equity, PBM reform, issues related to rare nephrology, 340B reform, psychedelics treatments for PTSD and mental health, BIOSECURE Act, and the Ensuring Pathways to Innovative Cures (EPIC) Act (S.832/HR 1492).
Foreign entity interest: Otsuka (Japan), identified on filer's Registration Statement (LD-1), as its parent organization has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HELEN DWIGHT | — |
| AMELIA SUERMANN | — |
Budget/Appropriations BUD
Provisions related to the Continuing Appropriations and Other Matters Act, 2025; and issues related to budget reconciliation.
Foreign entity interest: Otsuka (Japan), identified on filer's Registration Statement (LD-1), as its parent organization has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HELEN DWIGHT | — |
| AMELIA SUERMANN | — |
Taxation/Internal Revenue Code TAX
Issues related to tax reform efforts, issues stemming from the Tax Cuts and Jobs Act of 2017, and other corporate tax issues.
Foreign entity interest: Otsuka (Japan), identified on filers Registration Statement (LD-1), as its parent organization has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HELEN DWIGHT | — |
| AMELIA SUERMANN | — |
Veterans VET
Veterans Affairs, Mental Health, and post-traumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Veterans Affairs authorizations and appropriations issues related to mental health and PTSD.
Foreign entity interest: Otsuka (Japan), identified on filers Registration Statement (LD-1), as its parent organization has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HELEN DWIGHT | — |
| AMELIA SUERMANN | — |
Medicare/Medicaid MMM
Implementation of the Inflation Reduction Act. Issues related to Medicare Part D redesign's impact on low-income subsidy beneficiaries.
Foreign entity interest: Otsuka (Japan), identified on filer's Registration Statement (LD-1), as its parent organization has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HELEN DWIGHT | — |
| AMELIA SUERMANN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.